Orchard Therapeutics closes $150 million Series C round
The oversubscribed round comes just four months after acquisition of GSK's gene therapy portfolio.
Ghost Tree Capital Group
The oversubscribed round comes just four months after acquisition of GSK's gene therapy portfolio.